Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01821924 · ClinicalTrials.gov registry record
Role of Stress CMR in Predicting Adverse Clinical Events in Patients With Known or Suspected IHD
A clinical trial, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- 2,347
- Enrollment target
NCT01821924: Completed study, sponsored by Brigham and Women's Hospital.
NCT01821924 is a clinical trial that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 2,347 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01821924 has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- 2,347 participants
- Enrollment target
Study Summary
The investigators plan to use retrospective data to assess heart function and structure abnormalities through the use of an approved vasodilating agent for stress cardiac MRI tests. The investigators are interested in how these MRI findings relate to long-term prognosis in people who are at risk for cardiac disease.
Primary Outcome
"Myocardial infarction" will be defined as hospital admission for acute coronary syndrome (defined by positive serum troponin level with documented electrocardiographic changes, clinical syndrome, or need for percutaneous or surgical revascularization).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,347 participants |
| Start Date | 2012-01-30 |
| Est. Completion | 2018-08-30 |
What the finished NCT01821924 record still lists
NCT01821924 is an observational study that tracks outcomes without assigning an intervention. Its 2,347 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT01821924 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01821924 about?
NCT01821924 is a clinical study titled "Role of Stress CMR in Predicting Adverse Clinical Events in Patients With Known or Suspected IHD". The investigators plan to use retrospective data to assess heart function and structure abnormalities through the use of an approved vasodilating agent for stress cardiac MRI tests. The investigators are interested in how these MRI findings relate to long-term prognosis in people who are at risk for...
What is the current status of trial NCT01821924?
This trial is currently completed. The enrollment target is 2,347 participants. The study started on 2012-01-30. Estimated completion is 2018-08-30.
Who is sponsoring clinical trial NCT01821924?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03099850 · 2,345 participants
Prospective Evaluation of Chronic Pancreatitis for Epidemiologic and Translational Studies
- NCT00025935 · 2,350 participants
Studies of Brain Function and Course of Illness in Pediatric Bipolar Disorder
- NCT06679140 · 2,330 participants · Phase 3
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
- NCT05700760 · 2,320 participants · NA
The ROSE Scale-up Study: Informing a Decision About ROSE as Universal PPD Prevention
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI